Amneal Pharmaceuticals, Inc. AMRX FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s FX effect on cash?
- Amneal Pharmaceuticals, Inc. (AMRX) reported FX effect on cash of -$1.02M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s FX effect on cash changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s FX effect on cash decreased by 117.7% year-over-year, from -$470K to -$1.02M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s FX effect on cash?
- Over 2 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s FX effect on cash has grown at a -45.7% compound annual growth rate (CAGR), from -$5.71M to -$1.68M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.